Most medical conditions can be reduced in severity if treated early. Type 2 diabetes is one disease that can be delayed if appropriate action is taken. In fact, the condition can even be prevented in some cases, resulting in overall better health and potentially lower life insurance premiums.
People who know they are at a greater risk of developing type 2 diabetes can take measures to improve their health. Research released by the American Heart Association reveals that those with type 2 diabetes have different levels of ribonucleic acids (RNA) compared to those without the condition. Furthermore, microRNA 126 was found to be a strong indicator of those who are more likely to get type 2 diabetes.
Study author Dr. Manuel Mayr says he hopes the test will help better identify patients who need treatment.
"It's very important for the clinician to define those diabetic patients who are at the highest risk of developing cardiovascular complications," says Mayr. "We hope that this new class of blood markers may give additional insight that we're currently not getting from the other clinical tests."
There are currently more than 23 million people in the U.S. with type 2 diabetes and another 57 million with pre-diabetes, according to the American Diabetes Association.